This is the authors' abstract. We don't add key points for this paper.
Objective: To evaluate mobile applications available for patients undergoing assisted reproduction and assess the extent of their clinical validation. Methods: A systematic search was conducted in the Apple App Store and Google Play between September 1, 2023 and September 30, 2023 to identify mobile applications related to assisted reproduction. Apps were evaluated using the mobile app rating scale (MARS). In parallel, a literature search of PubMed, Scopus, Embase, and Web of Science was performed to identify clinical studies related to mobile applications in assisted reproduction. Clinical validation status and MARS scores were recorded, and findings were synthesized to highlight the gap between commercially available apps and research-based evidence. Results: From 1 143 apps screened, 11 met the inclusion criteria. Mean MARS score across apps was 3.63, with Leeaf scoring the highest (4.60). However, only one application (Embie) was supported by published research. The literature research identified 13 relevant studies, mostly randomized controlled trials, cohort studies, or usability studies. While research-based apps demonstrated clinical utility ( e.g. , MediEmo, PreLiFe, Patient Journey App), most were unavailable on app stores. This revealed a disconnect between research-backed applications and those accessible to patients. Conclusions: Although several mobile apps for assisted reproduction demonstrate high usability and quality, few are clinically validated. The lack of integration between research and practice highlights the need for stronger collaboration between researchers, developers, and policymakers to ensure that patients access safe and effective tools.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tran et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: